Christopher K. Murray Blueprint Medicines Corp (BPMC) insider trading activity

Christopher K. Murray is CHIEF TECHNICAL OPERATIONS of Blueprint Medicines Corp. Currently has a direct ownership of 33,853 shares of BPMC, which is worth approximately $2.92 Million. The most recent transaction as insider was on Mar 07, 2024, when has been sold 2,521 shares (Common Stock) at a price of $90.69 per share, resulting in proceeds of $228,629. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.9K

0% 3M change

31.75% 12M change

Total Value Held $2.92 Million

Christopher K. Murray Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 07 2024	SELL Open market or private sale	$228,629 $90.69 p/Share	2,521 Reduced 6.93%	33,853 Common Stock
Mar 04 2024	SELL Open market or private sale	$58,156 $93.65 p/Share	621 Reduced 1.68%	36,374 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	12,500 Added 25.26%	36,995 Common Stock
Feb 28 2024	SELL Open market or private sale	$500,000 $100.0 p/Share	5,000 Reduced 16.95%	24,495 Common Stock
Feb 28 2024	BUY Exercise of conversion of derivative security	$270,650 $54.13 p/Share	5,000 Added 14.49%	29,495 Common Stock
Dec 07 2023	SELL Open market or private sale	$375,000 $75.0 p/Share	5,000 Reduced 16.95%	24,495 Common Stock
Dec 07 2023	BUY Exercise of conversion of derivative security	$270,650 $54.13 p/Share	5,000 Added 14.49%	29,495 Common Stock
Dec 04 2023	SELL Open market or private sale	$42,858 $71.43 p/Share	600 Reduced 2.39%	24,495 Common Stock
Oct 26 2023	SELL Open market or private sale	$33,840 $56.4 p/Share	600 Reduced 2.34%	25,095 Common Stock
Mar 06 2023	SELL Open market or private sale	$84,375 $45.0 p/Share	1,875 Reduced 6.8%	25,695 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	8,750 Added 24.09%	27,570 Common Stock
Aug 05 2022	SELL Open market or private sale	$162,500 $65.0 p/Share	2,500 Reduced 11.73%	18,820 Common Stock
Aug 04 2022	SELL Open market or private sale	$151,100 $60.44 p/Share	2,500 Reduced 10.5%	21,320 Common Stock
Mar 07 2022	SELL Open market or private sale	$28,207 $56.19 p/Share	502 Reduced 2.06%	23,820 Common Stock
Mar 03 2022	SELL Open market or private sale	$64,248 $60.27 p/Share	1,066 Reduced 4.2%	24,322 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	6,500 Added 20.38%	25,388 Common Stock
Mar 04 2021	SELL Open market or private sale	$106,250 $87.81 p/Share	1,210 Reduced 6.02%	18,888 Common Stock
Mar 01 2021	BUY Grant, award, or other acquisition	-	6,250 Added 23.72%	20,098 Common Stock

CKM

Christopher K. Murray

CHIEF TECHNICAL OPERATIONS

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Value

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

Operation

Value

Type

News

Receive news related to Blueprint Medicines Corp

Track Activities on BPMC

Account